Shanna M. Miranti, MPAS, PA: Incorporating New Atopic Dermatitis Therapies into Clinical Practice
Shanna Miranti discusses how NPs and PAs can improve their patient care by taking advantage of the new options available to clinicians.
Julie Harper, MD: Rosacea Update
Dr. Harper recaps her session from Maui Derm NP+PA Fall, in which she discussed moving away from rosacea subtypes as well as new insights in rosacea pathogenesis and treatment.
Raj Chovatiya, MD, PhD: Atopic Dermatitis Update 2023
In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Chovatiya discusses the array of new drug approvals for AD, including biologics, oral drugs, and topicals, and how to choose between each option for our patients with AD.
Jonathan I. Silverberg, MD, PhD, MPH, FAAD: Patient Counseling in Atopic Dermatitis
Dr. Silverberg discusses how to safely counsel patients when deciding between topical versus oral JAK inhibitors for the treatment of atopic dermatitis.
Peter Lio, MD, FAAD: Sustainable Improvements for Patients with Atopic Dermatitis
Dr. Lio discusses the effects of topical ruxolitinib in his patients with atopic dermatitis, and how he incorporates this treatment into his practice.